Skip to main content
Erschienen in: AIDS and Behavior 7/2017

20.01.2017 | Original Paper

Concordance Between Self-Report and Performance-Based Measures of Everyday Functioning in HIV-Associated Neurocognitive Disorders

verfasst von: Talia N. Shirazi, Angela C. Summers, Bryan R. Smith, Sally R. Steinbach, Suad Kapetanovic, Avindra Nath, Joseph Snow

Erschienen in: AIDS and Behavior | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Self-report is typically used to differentiate between asymptomatic neurocognitive impairment (ANI) and mild neurocognitive disorder (MND) in the assessment of HIV-associated neurocognitive disorders (HAND). Yet, it is unclear whether the lack of self-reported functional impairments in individuals with ANI is indicative of a genuine absence of functional impairment, or of inaccurate self-reports. In the present study, we examined the relationship between previously validated self-report (patient’s assessment of own functioning inventory; instrumental activities of daily living inventory) and performance-based (the Texas Functional Living Scale) measures of functional abilities in 112 virologically-controlled HIV-infected, and 40 well-matched, HIV-uninfected participants. Participants with symptomatic cognitive impairment (CI) had significantly lower overall scores and higher rates of impairment on a performance-based measure of everyday functioning as compared to participants with either asymptomatic CI or normal cognitive performance (WNL [within normal limits]; all p < 0.05), while asymptomatic CI and WNL participants had comparable rates of impairment and performance within the average range on the performance-based measure. The concordance between self-report and performance-based measures of everyday functioning in asymptomatic and symptomatic CI provide support for ANI and MND as clinically distinct diagnostic entities, and support the use of self-reports as appropriate measures of everyday functioning in the diagnosis of HAND.
Literatur
1.
Zurück zum Zitat Janssen RS, Cornblath DR, Epstein LG, Foa RP. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology. 1991;41(6):778–85.CrossRef Janssen RS, Cornblath DR, Epstein LG, Foa RP. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology. 1991;41(6):778–85.CrossRef
2.
Zurück zum Zitat Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–99.CrossRefPubMedPubMedCentral Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–99.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology. 2010;75:2087–96.CrossRefPubMedPubMedCentral Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology. 2010;75:2087–96.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Grov C, Golub SA, Parsons JT, Brennan M, Karpiak SE. Loneliness and HIV-related stigma explain depression among older HIV-positive adults. AIDS Care. 2010;22(5):630–9.CrossRefPubMedPubMedCentral Grov C, Golub SA, Parsons JT, Brennan M, Karpiak SE. Loneliness and HIV-related stigma explain depression among older HIV-positive adults. AIDS Care. 2010;22(5):630–9.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Rao D, Pryor JB, Gaddist BW, Mayer R. Stigma, secrecy, and discrimination: ethnic/ratioal differences in the concerns of people living with HIV/AIDS. AIDS Behav. 2008;12(2):265–71.CrossRefPubMed Rao D, Pryor JB, Gaddist BW, Mayer R. Stigma, secrecy, and discrimination: ethnic/ratioal differences in the concerns of people living with HIV/AIDS. AIDS Behav. 2008;12(2):265–71.CrossRefPubMed
6.
Zurück zum Zitat Emlet CA. An examination of the social networks and social isolation in older and younger adults living with HIV/AIDS. Health Soc Work. 2006;31(4):299–308.CrossRefPubMed Emlet CA. An examination of the social networks and social isolation in older and younger adults living with HIV/AIDS. Health Soc Work. 2006;31(4):299–308.CrossRefPubMed
7.
Zurück zum Zitat Van Gorp WG, Satz P, Hinkin CH, Selnes O, Miller EN, McArthur J, et al. Metacognition in HIV-1 seropositive asymptomatic individuals: self-ratings versus objective neuropsychological performance. J Clin Exp Neuropsychol. 1991;13(5):812–9.CrossRefPubMed Van Gorp WG, Satz P, Hinkin CH, Selnes O, Miller EN, McArthur J, et al. Metacognition in HIV-1 seropositive asymptomatic individuals: self-ratings versus objective neuropsychological performance. J Clin Exp Neuropsychol. 1991;13(5):812–9.CrossRefPubMed
8.
Zurück zum Zitat Wilkins JW, Robertson KR, Snyder CR, Robertson WK, Van der Horst C, Hall CD. Implications of self-reported cognitive and motor dysfunction in HIV-positive patients. Am J Psychiatry. 1991;148:641–3.CrossRefPubMed Wilkins JW, Robertson KR, Snyder CR, Robertson WK, Van der Horst C, Hall CD. Implications of self-reported cognitive and motor dysfunction in HIV-positive patients. Am J Psychiatry. 1991;148:641–3.CrossRefPubMed
9.
Zurück zum Zitat Hinkin CH, Van Gorp WG, Satz P, Marcotte T, Durvasula RS, Wood S, et al. Actual versus self-reported cognitive dysfunction in HIV-1 infection: memory-metamemory dissociations. J Clin Exp Neuropsychol. 1996;18(3):431–43.CrossRefPubMed Hinkin CH, Van Gorp WG, Satz P, Marcotte T, Durvasula RS, Wood S, et al. Actual versus self-reported cognitive dysfunction in HIV-1 infection: memory-metamemory dissociations. J Clin Exp Neuropsychol. 1996;18(3):431–43.CrossRefPubMed
10.
Zurück zum Zitat Thames AD, Becker BW, Marcotte T, Hines L, Foley JM, Ramezani A, et al. Depression, cognition, and self-appraisal of functional abilities in HIV: an examination of subjective appraisal versus objective performance. Clin Neuropsychol. 2011;25(2):224–43.CrossRefPubMedPubMedCentral Thames AD, Becker BW, Marcotte T, Hines L, Foley JM, Ramezani A, et al. Depression, cognition, and self-appraisal of functional abilities in HIV: an examination of subjective appraisal versus objective performance. Clin Neuropsychol. 2011;25(2):224–43.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Juengst S, Skidmore E, Pramuka M, McCue M, Becker JT. Factors contributing to impaired self-awareness of cognitive functioning in an HIV positive and at-risk population. Disabil Rehabil. 2012;34(1):19–25.CrossRefPubMed Juengst S, Skidmore E, Pramuka M, McCue M, Becker JT. Factors contributing to impaired self-awareness of cognitive functioning in an HIV positive and at-risk population. Disabil Rehabil. 2012;34(1):19–25.CrossRefPubMed
12.
Zurück zum Zitat Moore LH, Van Gorp WG, Hinkin CH, Swales T, Satz P. Subjective complaints versus actual cognitive deficits in predominantly symptomatic HIV-1 seropositive individuals. J Neuropsychiatry Clin Neurosci. 1997;9:37–44.CrossRefPubMed Moore LH, Van Gorp WG, Hinkin CH, Swales T, Satz P. Subjective complaints versus actual cognitive deficits in predominantly symptomatic HIV-1 seropositive individuals. J Neuropsychiatry Clin Neurosci. 1997;9:37–44.CrossRefPubMed
13.
Zurück zum Zitat Schifitto G, Kieburtz K, McDermott MP, McArthur J, Marder K, Sacktor N, et al. Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes. Neurology. 2001;56(3):415–8.CrossRefPubMed Schifitto G, Kieburtz K, McDermott MP, McArthur J, Marder K, Sacktor N, et al. Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes. Neurology. 2001;56(3):415–8.CrossRefPubMed
14.
Zurück zum Zitat Chiao S, Rosen HJ, Nicolas K, Wendelken LA, Alcantar O, Rankin KP, et al. Deficits in self-awareness impact the diagnosis of Asymptomatic Neurocognitive Impairment in HIV. AIDS Res Hum Retrovir. 2013;29(6):949–56.CrossRefPubMedPubMedCentral Chiao S, Rosen HJ, Nicolas K, Wendelken LA, Alcantar O, Rankin KP, et al. Deficits in self-awareness impact the diagnosis of Asymptomatic Neurocognitive Impairment in HIV. AIDS Res Hum Retrovir. 2013;29(6):949–56.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Gandhi NS, Skolasky RL, Peters KB, Moxley RT, Creighton J, Roosa HV, et al. A comparison of performance-based measures of function in HIV-associated neurocognitive disorders. J Neurovirol. 2011;17:159–65.CrossRefPubMedPubMedCentral Gandhi NS, Skolasky RL, Peters KB, Moxley RT, Creighton J, Roosa HV, et al. A comparison of performance-based measures of function in HIV-associated neurocognitive disorders. J Neurovirol. 2011;17:159–65.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Blackstone K, Moore DJ, Heaton RK, Franklin DR, Woods SP, Clifford DB, et al. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc. 2012;18(1):79–88.CrossRefPubMed Blackstone K, Moore DJ, Heaton RK, Franklin DR, Woods SP, Clifford DB, et al. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc. 2012;18(1):79–88.CrossRefPubMed
17.
Zurück zum Zitat Feher EP, Mahurin RK, Inbody SB, Crook TH, Pirozzolo FJ. Anosognosia in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol. 1991;4:136–46. Feher EP, Mahurin RK, Inbody SB, Crook TH, Pirozzolo FJ. Anosognosia in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol. 1991;4:136–46.
18.
Zurück zum Zitat Gil R, Arroyo-Anllo EM, Ingrand P, Gil M, Neau JP, Ornon C, et al. Self-consciousness and Alzheimer’s disease. Acta Neurol Scand. 2001;104:296–300.CrossRefPubMed Gil R, Arroyo-Anllo EM, Ingrand P, Gil M, Neau JP, Ornon C, et al. Self-consciousness and Alzheimer’s disease. Acta Neurol Scand. 2001;104:296–300.CrossRefPubMed
19.
Zurück zum Zitat McDaniel KD, Edland SD, Heyman A. Relationship between level of insight and severity of dementia in Alzheimer’s disease. Alzheimer Dis Assoc Disord. 1995;9:101–4.CrossRefPubMed McDaniel KD, Edland SD, Heyman A. Relationship between level of insight and severity of dementia in Alzheimer’s disease. Alzheimer Dis Assoc Disord. 1995;9:101–4.CrossRefPubMed
20.
Zurück zum Zitat Aidala A, Havens J, Mellins CA, Dodds S, Whetten K, Martin DJ, et al. Development and validation of the Client Diagnostic Questionnaire (CDQ): a mental health screening tool for use in HIV/AIDS service settings. Psychol Health Med. 2004;9(3):362–80.CrossRef Aidala A, Havens J, Mellins CA, Dodds S, Whetten K, Martin DJ, et al. Development and validation of the Client Diagnostic Questionnaire (CDQ): a mental health screening tool for use in HIV/AIDS service settings. Psychol Health Med. 2004;9(3):362–80.CrossRef
21.
Zurück zum Zitat Beck AT. Beck depression inventory manual. San Antonio: Psychological Corporation; 1992. Beck AT. Beck depression inventory manual. San Antonio: Psychological Corporation; 1992.
22.
Zurück zum Zitat Green P. Green’s medical symptom validity test (MSVT) for Microsoft Windows (User Manual). Edmonton: Green’s Publishing; 2004. Green P. Green’s medical symptom validity test (MSVT) for Microsoft Windows (User Manual). Edmonton: Green’s Publishing; 2004.
23.
Zurück zum Zitat Schretlen DJ, Testa SM, Pearlson GD. Calibrated neuropsychological normative system (professional manual). Lutz: Psychological Assessment Resources; 2010. Schretlen DJ, Testa SM, Pearlson GD. Calibrated neuropsychological normative system (professional manual). Lutz: Psychological Assessment Resources; 2010.
24.
Zurück zum Zitat Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an Expanded Halstead–Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults (professional manual). Lutz: Psychological Assessment Resources; 2004. Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an Expanded Halstead–Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults (professional manual). Lutz: Psychological Assessment Resources; 2004.
25.
Zurück zum Zitat Heaton RK, Taylor MJ, Manly J, Tulsky DS. Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. In: Tulsky DS, Saklofske DH, Chelune GJ, et al., editors. Clinical interpretation of the WAIS-III and WMS-III. Burlington: Academic Press; 2003. p. 181–210.CrossRef Heaton RK, Taylor MJ, Manly J, Tulsky DS. Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. In: Tulsky DS, Saklofske DH, Chelune GJ, et al., editors. Clinical interpretation of the WAIS-III and WMS-III. Burlington: Academic Press; 2003. p. 181–210.CrossRef
26.
Zurück zum Zitat Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004;26(6):759–78.CrossRefPubMed Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004;26(6):759–78.CrossRefPubMed
27.
Zurück zum Zitat Chelune GJ, Heaton RK, Lehman RA. Neuropsychological and personality correlates of patients’ complaints of disability. In: Goldstein G, Tarter RE, editors. Advances in clinical neuropsychology. USA: Springer; 1986. p. 95–126.CrossRef Chelune GJ, Heaton RK, Lehman RA. Neuropsychological and personality correlates of patients’ complaints of disability. In: Goldstein G, Tarter RE, editors. Advances in clinical neuropsychology. USA: Springer; 1986. p. 95–126.CrossRef
28.
Zurück zum Zitat Richardson-Vejlgaard R, Dawes S, Heaton RK, Bell MD. Validity of cognitive complaints in substance-abusing patients and non-clinical controls: the Patient’s Assessment of Own Functioning Inventory (PAOFI). Psychiatry Res. 2009;169(1):70–4.CrossRefPubMedPubMedCentral Richardson-Vejlgaard R, Dawes S, Heaton RK, Bell MD. Validity of cognitive complaints in substance-abusing patients and non-clinical controls: the Patient’s Assessment of Own Functioning Inventory (PAOFI). Psychiatry Res. 2009;169(1):70–4.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Bell MJ, Terhorst L, Bender CM. Psychometric analysis of the Patient Assessment of Own Functioning Inventory in women with breast cancer. J Nurs Meas. 2013;21(2):320–34.CrossRefPubMedPubMedCentral Bell MJ, Terhorst L, Bender CM. Psychometric analysis of the Patient Assessment of Own Functioning Inventory in women with breast cancer. J Nurs Meas. 2013;21(2):320–34.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Heaton RK, Marcotte T, Mindt MR, Sadek J, Moore DJ, Bentley H, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10(3):317–31.CrossRefPubMed Heaton RK, Marcotte T, Mindt MR, Sadek J, Moore DJ, Bentley H, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10(3):317–31.CrossRefPubMed
31.
Zurück zum Zitat Cullum CM, Weiner M, Saine K. Texas Functional Living Scale: examiner’s manual. San Antonio: Pearson; 2009. Cullum CM, Weiner M, Saine K. Texas Functional Living Scale: examiner’s manual. San Antonio: Pearson; 2009.
32.
Zurück zum Zitat Cullum CM, Saine K, Lynette C, Martin-Cook K, Gray K, Weiner M. Performance-based instrument to assess functional capacity in dementia: the Texas Functional Living Scale. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14(2):103–8.PubMed Cullum CM, Saine K, Lynette C, Martin-Cook K, Gray K, Weiner M. Performance-based instrument to assess functional capacity in dementia: the Texas Functional Living Scale. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14(2):103–8.PubMed
33.
Zurück zum Zitat Drozdick LW, Cullum CM. Expanding the ecological validity of WAIS-IV and WMS-IV with the Texas Functional Living Scale. Assessment. 2010;18(2):141–55.CrossRefPubMedCentral Drozdick LW, Cullum CM. Expanding the ecological validity of WAIS-IV and WMS-IV with the Texas Functional Living Scale. Assessment. 2010;18(2):141–55.CrossRefPubMedCentral
34.
Zurück zum Zitat Weiner M, Davis B, Martin-Cook K, Hynan LS, Saine K, Cullum CM. A direct functional measure to help ascertain optimal level of resident care. Am J Alzheimers Dis Other Dement. 2007;22:355–9.CrossRef Weiner M, Davis B, Martin-Cook K, Hynan LS, Saine K, Cullum CM. A direct functional measure to help ascertain optimal level of resident care. Am J Alzheimers Dis Other Dement. 2007;22:355–9.CrossRef
35.
Zurück zum Zitat Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, et al. Prevalence of HIV-associated neurocognitive disorders in the Multicenter Aids Cohort study. Neurology. 2016;86(4):334–40.CrossRefPubMedPubMedCentral Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, et al. Prevalence of HIV-associated neurocognitive disorders in the Multicenter Aids Cohort study. Neurology. 2016;86(4):334–40.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Cysique LA, Brew BJ. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol. 2011;17(2):176–83.CrossRefPubMed Cysique LA, Brew BJ. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol. 2011;17(2):176–83.CrossRefPubMed
37.
Zurück zum Zitat Perry W, Hilsabeck RC, Hassanein TI. Cognitive dysfunction in chronic Hepatitis C: a review. Dig Dis Sci. 2008;53(2):307–21.CrossRefPubMed Perry W, Hilsabeck RC, Hassanein TI. Cognitive dysfunction in chronic Hepatitis C: a review. Dig Dis Sci. 2008;53(2):307–21.CrossRefPubMed
38.
Zurück zum Zitat Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic Hepatitis C. Hepatology. 2002;35(2):440–6.CrossRefPubMed Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic Hepatitis C. Hepatology. 2002;35(2):440–6.CrossRefPubMed
39.
Zurück zum Zitat Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev. 2009;19:169–85.CrossRefPubMed Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev. 2009;19:169–85.CrossRefPubMed
40.
Zurück zum Zitat Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes O, McArthur J, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8(2):136–42.CrossRefPubMed Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes O, McArthur J, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8(2):136–42.CrossRefPubMed
41.
Zurück zum Zitat Sacktor N, Lyles RH, Skolasky RL, Kleeberger C, Selnes O, Miller E. HIV associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990–1998. Neurology. 2001;56(2):257–60.CrossRefPubMed Sacktor N, Lyles RH, Skolasky RL, Kleeberger C, Selnes O, Miller E. HIV associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990–1998. Neurology. 2001;56(2):257–60.CrossRefPubMed
42.
Zurück zum Zitat Becker JT, Lopez OL, Dew MA, Aizenstein HJ. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS. 2004;18:11–8.CrossRef Becker JT, Lopez OL, Dew MA, Aizenstein HJ. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS. 2004;18:11–8.CrossRef
43.
Zurück zum Zitat Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte T, Grant I, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26(3):307–19.CrossRefPubMed Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte T, Grant I, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26(3):307–19.CrossRefPubMed
44.
Zurück zum Zitat Nurmi ME, Jehkonen M. Recognition and rehabilitation of impaired awareness of illness. Duodecim. 2015;131(3):228–34.PubMed Nurmi ME, Jehkonen M. Recognition and rehabilitation of impaired awareness of illness. Duodecim. 2015;131(3):228–34.PubMed
45.
Zurück zum Zitat Raison C, Capuron L, Miller A. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24–31.CrossRefPubMed Raison C, Capuron L, Miller A. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24–31.CrossRefPubMed
46.
Zurück zum Zitat Thames AD, Kim MS, Becker BW, Foley JM, Hines LJ, Singer EJ, et al. Medication and finance management among HIV-infected adults: the impact of age and cognition. J Clin Exp Neuropsychol. 2011;33(2):200–9.CrossRefPubMed Thames AD, Kim MS, Becker BW, Foley JM, Hines LJ, Singer EJ, et al. Medication and finance management among HIV-infected adults: the impact of age and cognition. J Clin Exp Neuropsychol. 2011;33(2):200–9.CrossRefPubMed
47.
Zurück zum Zitat Mindt MR, Cherner M, Marcotte TD, Moore DJ, Bentley H, Esquivel MM, et al. The functional impact of HIV-associated neuropsychological impairment in Spanish-speaking adults: a pilot study. J Clin Exp Neuropsychol. 2003;25(1):122–32.CrossRefPubMedPubMedCentral Mindt MR, Cherner M, Marcotte TD, Moore DJ, Bentley H, Esquivel MM, et al. The functional impact of HIV-associated neuropsychological impairment in Spanish-speaking adults: a pilot study. J Clin Exp Neuropsychol. 2003;25(1):122–32.CrossRefPubMedPubMedCentral
Metadaten
Titel
Concordance Between Self-Report and Performance-Based Measures of Everyday Functioning in HIV-Associated Neurocognitive Disorders
verfasst von
Talia N. Shirazi
Angela C. Summers
Bryan R. Smith
Sally R. Steinbach
Suad Kapetanovic
Avindra Nath
Joseph Snow
Publikationsdatum
20.01.2017
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 7/2017
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1689-6

Weitere Artikel der Ausgabe 7/2017

AIDS and Behavior 7/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.